Search research articles
Contact Us
Filters
Showing results (211-220 of 509) with videos related to
Page
of 51
Sort By:
Regulatory Peptides
|
August 19, 2007
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance
Filip K Knop, Tina Vilsbøll, Patricia V Højberg, et al.
Diabetes, Obesity & Metabolism
|
April 13, 2010
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
K Aaboe, F K Knop, T Vilsbøll, et al.
Peptides
|
April 14, 2024
Safety of native glucose-dependent insulinotropic polypeptide in humans
Mads M Helsted, Nina L Schaltz, Lærke S Gasbjerg, et al.
Journal of Hepatology
|
December 3, 2015
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease
Anders E Junker, Lise L Gluud, Gerrit van Hall, et al.
Peptides
|
July 29, 2015
Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation
Simon Veedfald, Astrid Plamboeck, Bolette Hartmann, et al.
European Journal of Endocrinology
|
June 18, 2014
The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects
N A Rhee, S H Østoft, J J Holst, et al.
Clinical Epidemiology
|
December 13, 2023
The Epidemiology of Bile Acid Diarrhea in Denmark
Martin L Kårhus, Anne-Marie Ellegaard, Matilde Winther-Jensen, et al.
Diabetologia
|
May 21, 2026
Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study
Alexander Abitbol, Michael C Riddell, Susan Peers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2014
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease
Thomas Idorn, Filip K Knop, Morten B Jørgensen, et al.
Diabetes, Obesity & Metabolism
|
September 8, 2025
Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022
Line Davidsen, Morten H Jensen, Asbjørn M Drewes, et al.
Page
of 51
Search research articles
Search
Showing results (211-220 of 509) with videos related to
Sort By:
Page
of 51
Regulatory Peptides
|
August 19, 2007
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance
Filip K Knop, Tina Vilsbøll, Patricia V Højberg, et al.
Diabetes, Obesity & Metabolism
|
April 13, 2010
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
K Aaboe, F K Knop, T Vilsbøll, et al.
Peptides
|
April 14, 2024
Safety of native glucose-dependent insulinotropic polypeptide in humans
Mads M Helsted, Nina L Schaltz, Lærke S Gasbjerg, et al.
Journal of Hepatology
|
December 3, 2015
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease
Anders E Junker, Lise L Gluud, Gerrit van Hall, et al.
Peptides
|
July 29, 2015
Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation
Simon Veedfald, Astrid Plamboeck, Bolette Hartmann, et al.
European Journal of Endocrinology
|
June 18, 2014
The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects
N A Rhee, S H Østoft, J J Holst, et al.
Clinical Epidemiology
|
December 13, 2023
The Epidemiology of Bile Acid Diarrhea in Denmark
Martin L Kårhus, Anne-Marie Ellegaard, Matilde Winther-Jensen, et al.
Diabetologia
|
May 21, 2026
Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study
Alexander Abitbol, Michael C Riddell, Susan Peers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2014
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease
Thomas Idorn, Filip K Knop, Morten B Jørgensen, et al.
Diabetes, Obesity & Metabolism
|
September 8, 2025
Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022
Line Davidsen, Morten H Jensen, Asbjørn M Drewes, et al.
Page
of 51